Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Introduction The T790M resistance mutation is present in about one-half of epidermal growth factor receptor (EGFR)-positive advanced non-small cell lung cancer (NSCLC) patients at disease progression. We aimed to assess the prevalence of this mutation in a real-world setting and the clinical impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Isabel, Gaspar, Cátia, Pina, Marta, Azevedo, Isabel, Rodrigues, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810175/
https://www.ncbi.nlm.nih.gov/pubmed/33489541
http://dx.doi.org/10.7759/cureus.12128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810175/
https://www.ncbi.nlm.nih.gov/pubmed/33489541
http://dx.doi.org/10.7759/cureus.12128

Ejemplares similares